Ergosta-7,22-diene-2β,3α,9α-triol (EGDT) from Ganoderma lucidum inhibits nasopharyngeal carcinoma cells by blocking EGFR signaling pathway
ConclusionThe treatment of EGDT displays EGFR and its mediated downstream signaling pathway blockade through decreasing the protein and mRNA levels, suggesting a promising strategy in treating human NPC.
Source: Chinese Herbal Medicines - Category: Complementary Medicine Source Type: research
More News: Cancer & Oncology | Carcinoma | China Health | Complementary Medicine | Ganoderma | Herbs | Nasopharyngeal Cancer